Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
May 1, 1987
Phase I study of two schedules of teroxirone
J Rubin, J S Kovach, M M Ames, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Mayo Clinic Proceedings
|
December 1, 1992
Locally recurrent non-small-cell lung cancer after complete surgical resection
E G Shaw, J S Brindle, E T Creagan, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
May 1, 1987
Phase I study of two schedules of teroxirone
J Rubin, J S Kovach, M M Ames, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Mayo Clinic Proceedings
|
December 1, 1992
Locally recurrent non-small-cell lung cancer after complete surgical resection
E G Shaw, J S Brindle, E T Creagan, et al.
Page
of 12